Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture
Public ClinicalTrials.gov record NCT05877066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Generating Real-world Ambispective Data to Study Participant Treatment Outcomes for Dupuytren's Contracture
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.
Study identification
- NCT ID
- NCT05877066
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 130 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 14, 2023 (Actual)
- Primary completion
- Feb 26, 2024 (Actual)
- Completion
- Feb 26, 2024 (Actual)
- Last update posted
- Apr 16, 2024
2023 – 2024
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Pharmaceuticals Clinical Site 6 | Phoenix | Arizona | 85015 | — |
| Endo Pharmaceuticals Clinical Site 5 | Greenwich | Connecticut | 06831 | — |
| Endo Pharmaceuticals Clinical Site 4 | Temple Terrace | Florida | 33637 | — |
| Endo Pharmaceuticals Clinical Site 2 | Indianapolis | Indiana | 46260 | — |
| Endo Pharmaceuticals Clinical Site 1 | Eatontown | New Jersey | 07774 | — |
| Endo Pharmaceuticals Clinical Site 7 | Charlotte | North Carolina | 28207 | — |
| Endo Pharmaceuticals Clinical Site 3 | Bend | Oregon | 97701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05877066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2024 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05877066 live on ClinicalTrials.gov.